Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
6.90
-0.23 (-3.23%)
Jan 29, 2026, 2:32 PM EST - Market open
Cybin Market Cap
Cybin has a market cap or net worth of $344.34 million as of January 29, 2026. Its market cap has increased by 93.43% in one year.
Market Cap
344.34M
Enterprise Value
288.47M
1-Year Change
93.43%
Ranking
Category
Stock Price
$6.90
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $344.34M, an increase of 277.99%. That is a compound annual growth rate of 29.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 355.81M | -12.84% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Autolus Therapeutics | 385.91M |
| Protara Therapeutics | 384.22M |
| Lineage Cell Therapeutics | 382.88M |
| Aclaris Therapeutics | 380.29M |
| Tectonic Therapeutic | 370.40M |
| Enanta Pharmaceuticals | 365.11M |
| PepGen | 358.87M |
| Neumora Therapeutics | 346.67M |